Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Abigail Glascock, Cole Maguire, Hoang Van Phan, Emily Lydon et autres
Azithromycin is a widely used antibiotic and was frequently used to treat hospitalized patients during the COVID-19 pandemic. The impact of empiric azithromycin use on the respiratory microbiome in patients with viral respiratory infections is unclear. Here we used longitudinal metatranscriptomics on …
us, at (code pays fourni par la source)
1 citation
Nature Microbiology